Head & Neck Cancers

The OncLive Head and Neck Cancer condition center page is a comprehensive resource for clinical news and expert insights on treatment for patients with head and neck cancer. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research within head and neck cancer.

Latest News

Bernard Doger de Spéville, MD, PhD
TACTI-002 Data Show Antitumor Activity With Second-Line Eftilagimod Alpha and PD-1 Inhibition in HNSCC

September 1st 2023

Bernard Doger de Spéville, MD, PhD, discusses the investigation of eftilagimod alpha plus pembrolizumab in the TACTI-002 trial, including prior evidence supporting this approach, the trial’s design and primary objective, and the combination’s efficacy and safety in both the head and neck squamous cell carcinoma and non–small cell lung cancer cohorts.

FDA Grants Fast Track Status to ALE.C04 for Recurrent or Metastatic CLDN1+ HNSCC
FDA Grants Fast Track Status to ALE.C04 for Recurrent or Metastatic CLDN1+ HNSCC

August 25th 2023

Gregory Lubiniecki, MD
LEAP-010 Trial Discontinued After OS Projection With Pembrolizumab/Lenvatinib in Metastatic HNSCC

August 25th 2023

David Hyman, MD
Selpercatinib Significantly Improves PFS Over MKIs in RET-Mutant Medullary Thyroid Cancer

August 22nd 2023

FDA
FDA Issues CRL to NDA for Avasopasem in Radiotherapy-Induced Severe Oral Mucositis in Head and Neck Cancer

August 9th 2023

Video Series
Video Interviews
Podcasts
Latest CME Events & Activities

25th Annual International Lung Cancer Congress®

Register Now!

BURST CME™: Utilizing Pathology Reports to Inform Treatment Plans Across GI Cancers

View More

Bridging the Care Gap in Anemia in CKD: A Comprehensive Guide to Enhancing Patient Care

Register Now!

2022 BURST Year in Review™: Reflecting on Recent Evidence for Testing in Patients with GI Cancers

View More

2nd Annual International Congress on Pediatric Oncology

View More

2022 BURST Year in Review™: How Has Recent Evidence in Testing Elevated Outcomes in Patients with Lung Cancers

View More

Community Practice Connections™: 23rd Annual International Lung Cancer Congress®

View More

How CEACAM5 Expression Can Be Measured and Leveraged in NSCLC Care: Current Developments & Future Therapeutic Opportunities

Register Now!

PER's Breast Cancer Symposia in San Antonio

Register Now!

2023 Friday Satellite Symposia: Preceding the 65th ASH Annual Meeting and Exposition

Register Now!

Evolving Evidence in Pediatric Brain Cancer: Spotlight on MAPK Inhibitors

View More

BURST CME™: Addressing Current Standards and Unmet Needs in Patients with Metastatic Breast Cancer

View More

20th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®

View More

Equalizing Inequities™ in Multiple Myeloma Care: Shining a Light on Current Barriers and Opportunities for Improved Outcomes

View More

9th Annual School of Gastrointestinal Oncology® (SOGO®)

Register Now!

New York GU 17th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies

Register Now!

New Targets, New Treatments, and New Combinations for the Management of Advanced Prostate Cancer

View More

BURST CME™: What Is the Real Risk in Lower-Risk MDS?

View More

BURST CME™: How Does Transfusion Burden Impact Real-World Outcomes in MDS?

View More

BURST CME™: Understanding Transfusion Dependence in Lower-Risk MDS

View More

Advances In™ KRAS Inhibition: Modern Considerations In Targeting KRAS-Mutated Lung, Colorectal, And Pancreatic Cancers

View More

How We Do It™: Integrating Gene Fusion Testing in Oncology Clinics for Patients with NSCLC

View More

A Focus on Acute Myeloid Leukemia

View More

Updates in Myelodysplastic Syndromes

View More

The Latest on Acute Lymphocytic Leukemia

View More

MAPK Pathway Inhibitors Augment Treatments for Pediatric Low-Grade Gliomas

View More

Medical Crossfire®: Key Strategies to Prioritize Testing and the Evolving Role of Genomic Alterations in Providing Precision NSCLC Care

View More

Community Practice Connections™: The Newest Frontier in HR+ Breast Cancer—Targeting ESR1 Mutations with Next-Generation Endocrine Therapy

View More

Medical Crossfire®: Onco-Nursing Best Practices for Managing AEs Related to CAR T-Cell Therapy from Treatment Center to Community

View More

Medical Crossfire®: Critical Questions on Diagnosis, Sequencing, and Selection of Systemic and Radioligand Therapy Options for Patients with GEP-NETs

View More

More News